You Position: Home > Paper
无保护左主干病变经皮介入治疗的临床观察
( views:225, downloads:4 )
- Author:
- No author available
- Journal Title:
- CHINA PRACTICAL MEDICAL
- Issue:
- 16
- DOI:
- 10.3969/j.issn.1673-7555.2009.16.142
- Key Word:
- 无保护左主干病变;经皮冠状动脉介入;预后
Abstract： 目的 探讨经皮冠状动脉介入(percutaneous coronary intervention,PCI)治疗无保护左主干(unprotected 1eft main coronary artery,ULMCA)病变的临床疗效.方法 本院2007年1月至2008年8月接受PCI的19例无保护左主干病变的患者进行门诊随访,观察主要心脏事件及近、远期疗效.结果 手术即刻成功率100%,无严重术中并发症,所有患者置架处血流均达TIMIⅢ级.所有患者住院期间无主要心脏不良事件(major adverse cardiac events,MACE)发生并完成随访,最长随访时间20个月,最短随访时间1个月,平均随访时间(12.32±5.70)个月.所有患者病情均稳定,心绞痛症状得到不同程度缓解,一般日常活动无心绞痛发作.结论 对经过选择的无保护左主干病变患者进行支架置入是安全可行的,并有良好的近、远期疗效.
- [1]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.经皮冠状动脉介入治疗指南[J].2004,(1).
- [2]Aragon J,Kass R,Lee MS,etc.Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease.[J].2006,47(4).
- [3]T M, Dewey,M J, Magee,J R, Edgerton,etc.Off-pump bypass grafting is safe in patients with left main coronary disease.[J].2001,72(3).
- [4]Costa RA,Price MJ,Leon MB,etc.Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization.[J].2006,47(4).
- [5]Marco, Valgimigli,Carlos A G, van Mieghem,Andrew T L, Ong,etc.Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RES[J].2005,111(11).